EdgarLookup

Seneca Foods Corp — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Seneca Foods Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
3.1%
Profit Margin
Net income ÷ revenue
3.5%
Return on Assets
Net income ÷ assets
0.87x
Debt-to-Equity
Total liabilities ÷ equity
+239.1%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2017 Mar 31, 2018 $1.31B Jun 29, 2018
FY2017 Dec 30, 2017 $387.69M Jun 29, 2018
FY2017 Sep 30, 2017 $338.47M Jun 29, 2018
FY2017 Jul 1, 2017 $288.93M Jun 29, 2018
FY2017 Mar 31, 2017 $280.69M Jun 29, 2018
FY2017 Dec 31, 2016 $356.77M Jun 29, 2018
FY2017 Oct 1, 2016 $352.61M Jun 29, 2018
FY2017 Jul 2, 2016 $272.14M Jun 29, 2018
FY2017 Mar 31, 2016 $1.28B Jun 29, 2018

Revenue (Net Sales)

Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.

Fiscal Year Period End Value Filed
FY2016 Mar 31, 2017 $1.25B May 25, 2017
FY2015 Mar 31, 2016 $1.28B Jun 8, 2016
FY2014 Mar 31, 2015 $1.29B Jun 9, 2015
FY2013 Mar 31, 2014 $1.34B May 22, 2014
FY2012 Mar 31, 2013 $1.28B May 23, 2013
FY2011 Mar 31, 2012 $1.26B Jun 8, 2012
FY2011 Mar 31, 2011 $1.19B Jun 8, 2012
FY2011 Mar 31, 2010 $1.28B Jun 8, 2012

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2018 Mar 31, 2018 $81.00M Jun 13, 2019
FY2017 Dec 30, 2017 $30.50M Jun 29, 2018
FY2017 Sep 30, 2017 $17.41M Jun 29, 2018
FY2017 Jul 1, 2017 $15.54M Jun 29, 2018
FY2017 Mar 31, 2017 $21.10M Jun 29, 2018
FY2017 Dec 31, 2016 $37.93M Jun 29, 2018
FY2017 Oct 1, 2016 $31.03M Jun 29, 2018
FY2017 Jul 2, 2016 $21.96M Jun 29, 2018
FY2017 Mar 31, 2016 $150.58M Jun 29, 2018

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $41.22M Jun 12, 2025
FY2025 Mar 31, 2024 $63.32M Jun 12, 2025
FY2025 Mar 31, 2023 $9.23M Jun 12, 2025
FY2024 Mar 31, 2022 $46.20M Jun 13, 2024
FY2023 Mar 31, 2021 $126.10M Jul 31, 2023
FY2021 Mar 31, 2020 $52.34M Jun 11, 2021
FY2019 Mar 31, 2019 $5.75M Jul 2, 2020
FY2018 Mar 31, 2018 ($8.48M) Jun 13, 2019
FY2017 Dec 30, 2017 $4.38M Jun 29, 2018
FY2017 Sep 30, 2017 ($2.96M) Jun 29, 2018

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $77.77M Jun 12, 2025
FY2025 Mar 31, 2024 $107.23M Jun 12, 2025
FY2025 Mar 31, 2023 $21.36M Jun 12, 2025
FY2024 Mar 31, 2022 $64.01M Jun 13, 2024
FY2023 Mar 31, 2021 $181.07M Jul 31, 2023
FY2021 Mar 31, 2020 $70.52M Jun 11, 2021
FY2019 Mar 31, 2019 ($38.08M) Jul 2, 2020
FY2018 Mar 31, 2018 $14.83M Jun 13, 2019
FY2017 Dec 30, 2017 $10.27M Jun 29, 2018
FY2017 Sep 30, 2017 ($1.41M) Jun 29, 2018

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $75.46M Jun 12, 2025
FY2025 Mar 31, 2024 $81.21M Jun 12, 2025
FY2025 Mar 31, 2023 $81.07M Jun 12, 2025
FY2024 Mar 31, 2022 $76.34M Jun 13, 2024
FY2023 Mar 31, 2021 $79.95M Jul 31, 2023
FY2021 Mar 31, 2020 $76.97M Jun 11, 2021
FY2019 Mar 31, 2019 $72.55M Jul 2, 2020
FY2018 Mar 31, 2018 $70.19M Jun 13, 2019
FY2017 Mar 31, 2017 $73.00M Jun 29, 2018
FY2017 Mar 31, 2016 $73.52M Jun 29, 2018

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $335.48M Jun 12, 2025
FY2025 Mar 31, 2024 ($82.96M) Jun 12, 2025
FY2025 Mar 31, 2023 ($212.80M) Jun 12, 2025
FY2024 Mar 31, 2022 $30.15M Jun 13, 2024
FY2023 Mar 31, 2021 $183.18M Jul 31, 2023
FY2021 Mar 31, 2020 $127.32M Jun 11, 2021
FY2019 Mar 31, 2019 $97.12M Jul 2, 2020
FY2018 Mar 31, 2018 ($13.19M) Jun 13, 2019
FY2017 Mar 31, 2017 $24.32M Jun 29, 2018
FY2017 Mar 31, 2016 $39.16M Jun 29, 2018

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $37.23M Jun 12, 2025
FY2025 Mar 31, 2024 $36.64M Jun 12, 2025
FY2025 Mar 31, 2023 $70.63M Jun 12, 2025
FY2024 Mar 31, 2022 $53.37M Jun 13, 2024
FY2023 Mar 31, 2021 $71.43M Jul 31, 2023
FY2021 Mar 31, 2020 $65.69M Jun 11, 2021
FY2019 Mar 31, 2019 $37.73M Jul 2, 2020
FY2018 Mar 31, 2018 $32.67M Jun 13, 2019
FY2017 Mar 31, 2017 $32.14M Jun 29, 2018
FY2017 Mar 31, 2016 $9.86M Jun 29, 2018

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $1.18B Jun 12, 2025
FY2025 Mar 31, 2024 $1.38B Jun 12, 2025
FY2025 Mar 31, 2023 $1.21B Jun 12, 2025
FY2023 Mar 31, 2022 $942.27M Jul 31, 2023
FY2022 Mar 31, 2021 $909.35M Jun 10, 2022
FY2021 Mar 31, 2020 $909.31M Jun 11, 2021
FY2019 Mar 31, 2019 $848.88M Jul 2, 2020
FY2018 Mar 31, 2018 $1.03B Jun 13, 2019
FY2017 Dec 30, 2017 $1.13B Jun 29, 2018
FY2017 Sep 30, 2017 $1.27B Jun 29, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $548.41M Jun 12, 2025
FY2025 Mar 31, 2024 $801.10M Jun 12, 2025
FY2024 Mar 31, 2023 $657.97M Jun 13, 2024
FY2023 Mar 31, 2022 $363.24M Jul 31, 2023
FY2022 Mar 31, 2021 $331.53M Jun 10, 2022
FY2021 Mar 31, 2020 $514.95M Jun 11, 2021
FY2019 Mar 31, 2019 $431.40M Jul 2, 2020
FY2018 Mar 31, 2018 $617.78M Jun 13, 2019
FY2017 Dec 30, 2017 $711.80M Jun 29, 2018
FY2017 Sep 30, 2017 $853.20M Jun 29, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $633.02M Jun 12, 2025
FY2025 Mar 31, 2024 $582.89M Jun 12, 2025
FY2025 Mar 31, 2023 $554.75M Jun 12, 2025
FY2025 Mar 31, 2022 $579.03M Jun 12, 2025
FY2022 Mar 31, 2021 $577.82M Jun 10, 2022
FY2021 Mar 31, 2020 $394.36M Jun 11, 2021
FY2019 Mar 31, 2019 $417.49M Jul 2, 2020
FY2018 Mar 31, 2018 $411.06M Jun 13, 2019
FY2017 Dec 30, 2017 $422.44M Jun 29, 2018
FY2017 Sep 30, 2017 $418.74M Jun 29, 2018

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $745.76M Jun 12, 2025
FY2025 Mar 31, 2024 $704.55M Jun 12, 2025
FY2024 Mar 31, 2023 $641.26M Jun 13, 2024
FY2023 Mar 31, 2022 $632.05M Jul 31, 2023
FY2022 Mar 31, 2021 $585.87M Jun 10, 2022
FY2021 Mar 31, 2020 $459.80M Jun 11, 2021
FY2019 Mar 31, 2019 $409.50M Jul 2, 2020
FY2018 Mar 31, 2018 $403.78M Jun 13, 2019
FY2017 Mar 31, 2017 $401.07M Jun 29, 2018
FY2016 Mar 31, 2016 $397.54M May 25, 2017

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $42.69M Jun 12, 2025
FY2025 Mar 31, 2024 $4.48M Jun 12, 2025
FY2024 Mar 31, 2023 $5.24M Jun 13, 2024
FY2023 Mar 31, 2022 $10.90M Jul 31, 2023
FY2022 Mar 31, 2021 $59.84M Jun 10, 2022
FY2021 Mar 31, 2020 $10.70M Jun 11, 2021
FY2019 Mar 31, 2019 $11.48M Jul 2, 2020
FY2019 Mar 31, 2018 $15.10M Jul 2, 2020
FY2018 Mar 31, 2017 $11.99M Jun 13, 2019
FY2017 Mar 31, 2016 $8.60M Jun 29, 2018

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $369.88M Jun 12, 2025
FY2025 Mar 31, 2024 $604.79M Jun 12, 2025
FY2023 Mar 31, 2023 $443.31M Jul 31, 2023
FY2022 Mar 31, 2022 $113.62M Jun 10, 2022
FY2022 Mar 31, 2021 $98.59M Jun 10, 2022
FY2021 Mar 31, 2020 $217.58M Jun 11, 2021
FY2019 Mar 31, 2019 $266.25M Jul 2, 2020
FY2018 Mar 31, 2018 $409.40M Jun 13, 2019
FY2017 Mar 31, 2017 $332.63M Jun 29, 2018
FY2016 Mar 31, 2016 $315.54M May 25, 2017

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 5 Jun 12, 2025
FY2025 Mar 31, 2024 8 Jun 12, 2025
FY2025 Mar 31, 2023 1 Jun 12, 2025
FY2024 Mar 31, 2022 5 Jun 13, 2024
FY2023 Mar 31, 2021 13 Jul 31, 2023
FY2021 Mar 31, 2020 5 Jun 11, 2021
FY2019 Mar 31, 2019 0 Jul 2, 2020
FY2018 Mar 31, 2018 0 Jun 13, 2019
FY2017 Dec 30, 2017 0 Jun 29, 2018
FY2017 Sep 30, 2017 0 Jun 29, 2018

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 5 Jun 12, 2025
FY2025 Mar 31, 2024 8 Jun 12, 2025
FY2025 Mar 31, 2023 1 Jun 12, 2025
FY2024 Mar 31, 2022 5 Jun 13, 2024
FY2023 Mar 31, 2021 13 Jul 31, 2023
FY2021 Mar 31, 2020 5 Jun 11, 2021
FY2019 Mar 31, 2019 0 Jul 2, 2020
FY2018 Mar 31, 2018 0 Jun 13, 2019
FY2017 Dec 30, 2017 0 Jun 29, 2018
FY2017 Sep 30, 2017 0 Jun 29, 2018